J. Clin. Lab. Anal. volume 29, issue 6, P498-504 2014 DOI: 10.1002/jcla.21800 View full text
|
|
Share
Zhigang Hu, Mei Li, Jie Liu, Lei Yu, Yifeng Xue, Yu Chen

Abstract: The TR-IFMA that we developed for L protein presented a higher sensitivity and wider detecting range than regular commercial ELISA. Therefore, this TR-IFMA has promising value both in the screening of HBV and monitoring of antiviral therapy.